drugset / Trial / NCT02956993

Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)

NCT02956993 ↗

Phase 1 Completed 29 enrolled Proteon Therapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The research study is designed to assess the technical feasibility and safety of a perivascular injection of vonapanitase delivered via micro-infusion catheter to the distal popliteal, tibial or peroneal arteries immediately following successful angioplasty.

Timeline

Start
2016-11
Primary completion
2019-04-30
Completion
2019-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator vonapanitase Protein / enzyme biologic — Other